See page 9 for Co-op City Times Survey
Vol. 56 No. 28
Saturday, July 10, 2021
NYC BOE primary election update
Adams declares victory, Garcia & Wiley concede BY TORIEA McCAUSELAND
Mayoral race Eric Adams – 50.5% Kathryn Garcia – 49.5% A week after the New York City Board of Election’s unofficial results snafu, the organization released an update on votes – including Ranked Choice Voting and absentee ballots – declaring Eric Adams as the winner. With his primary finally over, Adams tweeted on Tuesday, July 6, “I grew up poor in Brooklyn & Queens. I wore a bulletproof vest to keep my neighbors safe. I served my community as a State Senator & Brooklyn Borough President. And I’m honored to be the Democratic nominee to be the mayor of the city I’ve always called home. Thank you, New York!” Eric Adams Shortly after the BOE released its updated results, major news outlets such as The New York Times and Associated Press reported Adams as the winner in the Democratic mayoral primary.
$1.25
Rep. Bowman Visits Power Plant On Friday, July 9, Congressman Jamaal Bowman and congressional staff members met with Riverbay leadership including Board President Bernie Cyclich, First Vice President Sonia Felicano and Treasurer Claudia Sampson, along with Executive General Manager Bob Klehammer , General Manager Noel Ellison and others, to get an overview of the community. The congressman said he wanted his team to see and learn about Co-op City in order to best serve his constituents in the 16th congressional district. He said, “You have to be present to really serve all communities.” The congressman and his staff toured the Riverbay’s Power Plant and visited a model apartment. --Tori McCauseland
(Continued on page 4)
Riverbay Counsel explains proposed state laws’ impact on shareholders BY JEFF BUSS
The New York State Legislature recently enacted two laws which will impose additional costs on Co-op City shareholders if they are signed into law by the Governor. The first law, known as Senate Bill S6412, would change the way Co-op City conducts elections, conducts Board meetings and utilizes community rooms. With regard to elections, the proposed law requires that shareholders vote “in-person,” with a paper ballot that can be audited, or by an “absentee ballot,” that contains the shareholder’s signature and is contained within two sealed envelopes. These requirements would require Co-op City to change the way it (Continued on page 4)
Voter participation in the 2021 Riverbay Board of Directors election BY ROZAAN BOONE
Residents of the Broun Place Townhouse cluster scored $500 in voting incentive prize money for their townhouse association by having the highest voter turnout percentage – 52.86% – in the 2021 Riverbay Board of Directors election. This year’s voting period in the annual Board election initially ran from May 3 – May 21, 2021 and a quorum of 4,998 ballots were required to validate the election, as stipulated in the Riverbay By-laws. This number – 4,998 – represented 1/3 of the total number of Co-op City shareholders of record as of March 30, 2021. To encourage shareholders to participate in the election of their representatives to the resident Board of Directors that sets policy for the Riverbay Corporation, the Riverbay Board approved a voting incentive of $200 to each of 12 shareholders who voted in the election. Names were selected in a random computer(Continued on page 9)
Power Plant Asset Manager Anthony Ligato (top, right) conducts tour with Congressman Bowman and staff. The entourage also visited a model apartment. Photos By Brandon Ortiz
Study finds Johnson & Johnson Vaccine Effective Fights against serious COVID-19 Infections and Virus Variants BY BRANDON ORTIZ
Johnson and Johnson had some encouraging news recently when the company announced the results from an ongoing clinical trial of their COVID-19 vaccine. Results from the clinical trial, specifically Phase 3 of the ENSEMBLE study, found Johnson and Johnson’s vaccine to be effective against serious COVID-19 infections and virus variants. In fact, the study found Johnson and Johnson vaccines to be 85% effective in preventing serious COVID-19 infections. The data also showed the Johnson and Johnson vaccine provides protection from the virus for at least eight months, which is the latest point in time recorded by the study so far. Equally importantly, the study found the vaccine to be competent against rising COVID-19 variants, especially the Delta variant. In total, the study enrolled 43,783 participants across eight countries including the U.S. “Current data for the eight months studied so far show that the single-shot Johnson & Johnson COVID-19 vaccine generates a strong neutralizing antibody response that does not wane; rather, we observe an improvement over time. In addition, we observe a persistent and particularly robust, durable cellular (Continued on page 2)